Dear Friends, Supporters, and Valued Partners of the ICPO Foundation,

We would like to thank you for your participation at the ICPO Theranostics FAP Summit, as one of more than 397 participants from 35 different countries you truly contributed to make this FAP Summit a success!

This is what ICPO is all about: advancing innovative therapies in the field of molecular precision oncology on an international level and ultimately providing greater and more democratic access to patients worldwide.

We sincerely hope that you enjoyed the program including the interactive panels.

Before we say goodbye and start planning for 2023 we would like to point out that:

• Most of the talks are available on demand on the ICPO FAP Summit platform until 31 January 2023: https://ssm-live.com/ICPO/
• Your personalized login credentials stay the same
• All our 9 sponsors and their profiles are featured on the platform for further contact
• If you or your organization would like to join the ICPO Foundation as a ICPO Supporter Member or ICPO Partner Member, please refer to https://www.icpo.foundation/members/ for further information.
• Would you like to donate to the ICPO Foundation, please refer to https://www.icpo.foundation/donate/ for further information.



SNMMI 2019 Image of the Year: 68Ga-FAPI-PET/CT in patients reflecting 12 different tumor entities.

  • Ca = cancer; NSCLC = non-small cell lung cancer;
  • CUP = carcinoma of unknown primary;
  • CCC = cholangiocarcinoma;
  • GEP-NET= Gastroenteropancreatic neuroendocrine tumor.

Image Credit: Image created with contributions from Clemens Kratochwil, Paul Flechsig, Thomas Lindner, Labidi Abderrahim, Annette Altmann, Walter Mier, Sebastian Adeberg, Hendrik Rathke, Manuel Röhrich, Hauke Winter, Peter Plinkert, Frederik Marme, Matthias Lang, Hans Ulrich Kauczor, Dirk Jaeger, Juergen Debus, Uwe Haberkorn, Frederik L. Giesel; all contributors are affiliated with University Hospital Heidelberg, Germany.

Copyright 2022 EUROKONGRESS GmbH. All Rights Reserved.